Literature DB >> 9818030

Caspase-3 activation is not responsible for vinblastine-induced Bcl-2 phosphorylation and G2/M arrest in human small cell lung carcinoma Ms-1 cells.

E Tashiro1, S Simizu, M Takada, K Umezawa, M Imoto.   

Abstract

Vinblastine arrests cells in the G2/M phase of the cell cycle and subsequently induces cell death by apoptosis. We found that treatment of cells with vinblastine induced phosphorylation of Bcl-2, resulting in the dissociation of Bcl-2 and Bax. Moreover, vinblastine-induced apoptosis was suppressed by an inhibitor of caspase-3, Ac-DEVD-CHO; and a 17-kDa active fragment of caspase-3 was detected following vinblastine treatment, suggesting that caspase-3 is involved in vinblastine-induced apoptosis. However, Ac-DEVD-CHO affected neither vinblastine-induced Bcl-2 phosphorylation nor vinblastine-induced G2/M arrest. Vinblastine caused G2/M arrest prior to apoptosis, whereas vinblastine-induced apoptosis was not dependent on the duration of the G2/M phase. Thus, vinblastine-induced apoptosis might be mediated by the phosphorylation of Bcl-2, resulting in Bcl-2 inactivation, and by subsequent activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818030      PMCID: PMC5921943          DOI: 10.1111/j.1349-7006.1998.tb00652.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Mechanism of inhibition of cell proliferation by Vinca alkaloids.

Authors:  M A Jordan; D Thrower; L Wilson
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

2.  Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3).

Authors:  R J Guan; B S Khatra; J A Cohlberg
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

3.  Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.

Authors:  A M Ibrado; L Liu; K Bhalla
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

4.  Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death.

Authors:  P L Simonian; D A Grillot; D W Andrews; B Leber; G Nuñez
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

5.  Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.

Authors:  A M Ibrado; Y Huang; G Fang; L Liu; K Bhalla
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

6.  Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.

Authors:  A M Ibrado; Y Huang; G Fang; K Bhalla
Journal:  Cell Growth Differ       Date:  1996-08

Review 7.  A comparison of the biological activities of wild-type and mutant p53.

Authors:  G P Zambetti; A J Levine
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

Review 8.  Programmed cell death in Caenorhabditis elegans.

Authors:  M O Hengartner; H R Horvitz
Journal:  Curr Opin Genet Dev       Date:  1994-08       Impact factor: 5.578

9.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes.

Authors:  K L Wendell; L Wilson; M A Jordan
Journal:  J Cell Sci       Date:  1993-02       Impact factor: 5.285

View more
  5 in total

1.  Enhanced antitumor activity of irofulven in combination with antimitotic agents.

Authors:  Michael J Kelner; Trevor C McMorris; Rafael J Rojas; Nicole A Trani; Tami R Velasco; Leita A Estes; Pharnuk Suthipinijtham
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

2.  An ion-current-based, comprehensive and reproducible proteomic strategy for comparative characterization of the cellular responses to novel anti-cancer agents in a prostate cell model.

Authors:  Chengjian Tu; Jun Li; Yahao Bu; David Hangauer; Jun Qu
Journal:  J Proteomics       Date:  2012-09-07       Impact factor: 4.044

3.  Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells.

Authors:  Mohammad Hassan Naseri; Majid Mahdavi; Jamshid Davoodi; Saeed Hesami Tackallou; Mahdi Goudarzvand; Shima Hallaj Neishabouri
Journal:  Cancer Cell Int       Date:  2015-05-28       Impact factor: 5.722

4.  Curcumin-Induced Autophagy Augments Its Antitumor Effect against A172 Human Glioblastoma Cells.

Authors:  Jong-Eun Lee; Sung Sik Yoon; Eun-Yi Moon
Journal:  Biomol Ther (Seoul)       Date:  2019-09-01       Impact factor: 4.634

5.  HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.

Authors:  Narissara Namwan; Gulsiri Senawong; Chanokbhorn Phaosiri; Pakit Kumboonma; La-Or Somsakeesit; Arunta Samankul; Chadaporn Leerat; Thanaset Senawong
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.